Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

614 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer.
Koole SN, Bruijs L, Fabris C, Sikorska K, Engbersen M, Schagen van Leeuwen JH, Schreuder HWR, Hermans RH, van der Velden J, Arts HJG, van Ham M, Van Dam P, Vuylsteke P, Lahaye M, Sonke G, Driel WV. Koole SN, et al. Among authors: van dam p, van ham m, van der velden j. Int J Gynecol Cancer. 2020 Dec;30(12):1928-1934. doi: 10.1136/ijgc-2020-001825. Epub 2020 Oct 12. Int J Gynecol Cancer. 2020. PMID: 33046576
Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis.
Samlal RA, Van Der Velden J, Van Eerden T, Schilthuis MS, Gonzalez Gonzalez D, Lammes FB. Samlal RA, et al. Among authors: van eerden t, van der velden j. Int J Gynecol Cancer. 1998 Jan;8(1):78-84. doi: 10.1046/j.1525-1438.1998.09759.x. Int J Gynecol Cancer. 1998. PMID: 11576287
Samlal RAK, van der Velden J, van Eerden T, Schilthuis MS, Gonzalez Gonzalez D, Lammes FB. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer 1998; 8: 78-84. The pu …
Samlal RAK, van der Velden J, van Eerden T, Schilthuis MS, Gonzalez Gonzalez D, Lammes FB. Recurrent cerv …
Tamoxifen in patients with advanced epithelial ovarian cancer.
Van Der Velden J, Gitsch G, Wain GV, Friedlander ML, Hacker NF. Van Der Velden J, et al. Int J Gynecol Cancer. 1995 Jul;5(4):301-305. doi: 10.1046/j.1525-1438.1995.05040301.x. Int J Gynecol Cancer. 1995. PMID: 11578494
Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.
Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A, Sluiter WJ. Van der Zee AG, et al. Among authors: van dorst eb, van der velden j, van der putten h. J Clin Oncol. 2008 Feb 20;26(6):884-9. doi: 10.1200/JCO.2007.14.0566. J Clin Oncol. 2008. PMID: 18281661 Free article. Clinical Trial.
Assessment of promising protein markers for vulva cancer.
Fons G, Burger MP, ten Kate FJ, van der Velden J. Fons G, et al. Among authors: van der velden j. Int J Gynecol Cancer. 2009 May;19(4):756-60. doi: 10.1111/IGC.0b013e3181a4071d. Int J Gynecol Cancer. 2009. PMID: 19509584
614 results